Agnieszka Bogusz-Wójcik

Dr. Agnieszka Bogusz-Wójcik

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Endocrine Connections
Verified
Journal Article
Open access
PDF file
ABAgnieszka Bogusz-Wójcik
Agnieszka Bogusz-Wójcik
SBSvenja Boekhoff
Svenja Boekhoff
MWMonika Warmuth-Metz
Monika Warmuth-Metz
GCGabriele Calaminus
Gabriele Calaminus
MEMaria Eveslage
Maria Eveslage
HMHermann L. Müller
Hermann L. Müller
Objective: Quality of life (QoL) is frequently impaired in childhood-onset craniopharyngioma (CP) by hypothalamic syndrome. The debate, whether pretreatment hypothalamic involvement (HI) has apriori prognostic impact or surgical hypothalamic lesions (HL) determine outcome, is controversial.Design: Survival and outcome of CPs recruited between 2007 and 2014 in KRANIOPHARYNGEOM 2007 were analyzed with regard to reference-confirmed presurgical HI and surgical HL.Methods: Radiological findings, BMI and QoL were assessed at diagnosis and during follow-up. QoL was assessed using Pediatric Quality of Life (PEDQOL) questionnaire.Results: One hundred sixty-nine CPs were included presenting with no HI (n = 11), anterior (n = 49) and anterior + posterior (a + p) HI (n = 109) prior to surgery. The latter 109 were analyzed for postoperative HL (no lesion:n = 23, anterior HL:n = 29, a + pHL:n = 57). Progression-free survival (PFS) was higher after complete resection. The highest PFS was observed in CP with a + pHL, especially when compared between non-irradiated subgroups (P = 0.006). Overall survival (OS) rates were 1.0 in all subgroups. CP with a + pHL developed higher BMI (P ≤ 0.001) during follow-up compared between subgroups. 55/109 pts with a + pHI completed PEDQOL at diagnosis (48/109 at 3 years follow-up). QoL was worse for a + pHL patients in terms of physical, social and emotional functionality when compared with the anterior HL and no HL subgroup. BMI development and QoL during follow-up were similar for patients with anterior HL and without HL.Conclusions: Posterior hypothalamus-sparing surgical strategies are associated with higher QoL, decreased development of obesity and lower PFS in CP.

1 November 2018 in European Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
SBSvenja Boekhoff
Svenja Boekhoff
ABAgnieszka Bogusz-Wójcik
Agnieszka Bogusz-Wójcik
ASAnthe S Sterkenburg
Anthe S Sterkenburg
MEMaria Eveslage
Maria Eveslage
HMHermann L. Müller
Hermann L. Müller
Objective: Quality of survival, prognosis and long-term outcome are often severely impaired in childhood-onset craniopharyngioma (CP) patients. Identification of risk factors for sequelae such as growth hormone (GH) deficiency is important for appropriate treatment and rehabilitation.Design: In a cross-sectional study, 79 CP patients recruited in HIT-Endo before 2000 were analyzed according to GH substitution: (a) CP never GH treated (noGH); (b) CP GH treated only during childhood (pedGH); (c) CP under GH, initiated at adulthood (adultGH); (d) CP under GH during childhood and continued during adulthood (contGH).Methods: Progression-free (PFS) and overall survival (OS), height, BMI, psychosocial and neuropsychological status (EORTC QLQ-C30, MFI-20).Results: OS and PFS rates were similar in all subgroups. ContGH and pedGH CP presented with increases in height (P = 0.002;P = 0.0001) during long-term follow-up when compared with baseline. In all subgroups except for pedGH, increases in BMI were observed when compared with BMI at diagnosis. For emotional functionality and physical fatigue, adultGH CP showed worse (P = 0.037;P = 0.034) response (mean: 61.4%; 12.5%) when compared with pedGH CP (mean: 83.5%; 7.7%). Observed differences were not related to irradiation and hypothalamic involvement. In terms of psychosocial status, no differences were observed between subgroups.Conclusions: We conclude that GH substitution was safe with regard to risk of tumor progression/relapse in CP. Growth was improved by GH, whereas the development of obesity was not influenced by GH substitution. However, early initiation of GH substitution after CP diagnosis might have beneficial effects on weight development and neuropsychological outcome.

24 September 2018 in Expert Review of Neurotherapeutics
Verified
Journal Article
Closed access
ABAgnieszka Bogusz-Wójcik
Agnieszka Bogusz-Wójcik
HMHermann L. Müller
Hermann L. Müller
Introduction: Childhood-onset craniopharyngiomas are rare embryonic tumors of low-grade histological malignancy. Severe obesity, physical fatigue and psychosocial deficits due to hypothalamic tumor involvement have negative impact on quality of life. Initial pretreatment involvement of hypothalamic structures and/or treatment-related lesions result in sequelae clinically associated with impaired social and physical functionality and severe neuroendocrine deficiencies. Overall and progression-free survival rates are not associated with the degree of surgical resection. However, reduced overall survival rates were observed in patients with primary hypothalamic tumor involvement. Areas covered: This review discusses new perspectives on diagnostics, treatment and follow-up of patients with childhood-onset craniopharyngioma, which were mostly published after 2010 and presented at the 5th International Multidisciplinary Postgraduate Course on Childhood Craniopharyngioma, 19-22 April, 2018, at Bad Zwischenahn, Germany. Expert Commentary: Percutaneous radiooncological treatment options are effective in prevention of relapses and tumor progressions. Initial experience with proton beam therapy in childhood-onset craniopharyngioma patients shows promising results in terms of more protective radiological treatment. Recent reports on the molecular pathogenesis of craniopharyngioma open perspectives on the possibility of testing novel treatments targeting pathogenic pathways. As long as effective treatment options for hypothalamic syndrome are not available, hypothalamus-sparing treatment strategies are recommended.

30 June 2021 in Endokrynologia Polska
Verified
Journal Article
Closed access
PDF file
ABAgnieszka Bogusz-Wójcik
Agnieszka Bogusz-Wójcik
HKHonorata Kołodziejczyk
Honorata Kołodziejczyk
EMElżbieta Moszczyńska
Elżbieta Moszczyńska
MKMaja Klaudel-Dreszler
Maja Klaudel-Dreszler
GOGrzegorz Oracz
Grzegorz Oracz
MSMieczysław Szalecki
Mieczysław Szalecki
Introduction Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive disorder characterized by pancreatic exocrine insufficiency, immune deficiency, bone marrow failure and bone malformations. Systematic data concerning endocrine function in SDS are limited. We studied patients diagnosed in The Children’s Memorial Health Institute in Warsaw, Poland, to assess the prevalence of various endocrinopathies. Material and Methods In the pilot study, retrospective data were collected for 5 patients with SDS. Subsequently, patients with SDS aged 3-16 years were recruited prospectively. In total, 19 patients with mutations in SBDS gene were studied. Data were collected on anthropometric measurements, systemic screening tests of pituitary, thyroid, adrenal, pancreatic and gonadal function as well as bone mineral density. Descriptive statistics were tabulated and group differences assessed. Results Twelve patients (63%) had ≥ one endocrine disorder, including growth hormone dysfunction (ten patients, 53%), hypothyroidism (two patients, 10%), congenital hypopituitarism (one patient, 5%), and/or type 1 diabetes (one patient, 5%). The group of boys presented with a significantly lower height (-2.1 SD, p<0.0001) and BMI (-1.0 SD, p<0.00001). The group of girls also showed significantly lower height (-2.6 SD, p<0.00001) and BMI (-0.7 SD, p<0.0001). All patients had significantly lower height than their mid-parental height. Delayed bone age was found in 15 patients (84%) and osteopenia in 12 of 15 patients (80%). Conclusions Endocrine dysfunctions are common in SDS, especially growth hormone deficiency. Children with poor growth can benefit from an endocrinological evaluation and tests for GH deficiency. Bone mineral density measurements should be a part of a routine screening. Longitudinal studies are needed to better understand the etiology and true prevalence of these disorders. Introduction Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive disorder characterized by pancreatic exocrine insufficiency, immune deficiency, bone marrow failure and bone malformations. Systematic data concerning endocrine function in SDS are limited. We studied patients diagnosed in The Children’s Memorial Health Institute in Warsaw, Poland, to assess the prevalence of various endocrinopathies. Material and Methods In the pilot study, retrospective data were collected for 5 patients with SDS. Subsequently, patients with SDS aged 3-16 years were recruited prospectively. In total, 19 patients with mutations in SBDS gene were studied. Data were collected on anthropometric measurements, systemic screening tests of pituitary, thyroid, adrenal, pancreatic and gonadal function as well as bone mineral density. Descriptive statistics were tabulated and group differences assessed. Results Twelve patients (63%) had ≥ one endocrine disorder, including growth hormone dysfunction (ten patients, 53%), hypothyroidism (two patients, 10%), congenital hypopituitarism (one patient, 5%), and/or type 1 diabetes (one patient, 5%). The group of boys presented with a significantly lower height (-2.1 SD, p<0.0001) and BMI (-1.0 SD, p<0.00001). The group of girls also showed significantly lower height (-2.6 SD, p<0.00001) and BMI (-0.7 SD, p<0.0001). All patients had significantly lower height than their mid-parental height. Delayed bone age was found in 15 patients (84%) and osteopenia in 12 of 15 patients (80%). Conclusions Endocrine dysfunctions are common in SDS, especially growth hormone deficiency. Children with poor growth can benefit from an endocrinological evaluation and tests for GH deficiency. Bone mineral density measurements should be a part of a routine screening. Longitudinal studies are needed to better understand the etiology and true prevalence of these disorders.

7 February 2020 in Child's Nervous System
Verified
Journal Article
Open access
PDF file
EMElżbieta Moszczyńska
Elżbieta Moszczyńska
MPMonika Prokop-Piotrkowska
Monika Prokop-Piotrkowska
ABAgnieszka Bogusz-Wójcik
Agnieszka Bogusz-Wójcik
WGWiesława Grajkowska
Wiesława Grajkowska
SSSylwia Szymańska
Sylwia Szymańska
MSMieczysław Szalecki
Mieczysław Szalecki
Purpose: Craniopharyngioma is one of the most frequent benign tumours of the central nervous system in the paediatric population. Although it is a benign tumour according to the WHO classification, it significantly deteriorates the patient’s quality of life. The aim of this study is to assess if proliferation index Ki67 can be a useful marker of the risk of craniopharyngioma’s recurrence.Methods: Expression of Ki67 was examined in 85 specimens of primary craniopharyngioma and in 11 specimens of the recurring tumour. In all the cases, adamantinomatous type of craniopharyngioma was diagnosed. Values of Ki67 expression were compared between patients with and without recurrence, between patients with progression and relapse and between primary and recurrent tumours.Results: No statistically significant differences were found between proliferation index Ki67 values in tumours with recurrence and without (median values 2.5% and 3%, respectively,p = 0.69). The median value of proliferation index Ki67 in progression group was 1% and in the relapse group 4%; no statistical significance between those groups was found (p = 0.067). The median value of proliferation index Ki67 in primary tumours was 3% (0–20%) and in recurrent tumours it was 5% (0–14%). Despite the lack of statistical significance (p = 0.61), a tendency towards higher values of Ki67 in recurring tumours in comparison with primary tumours was shown.Conclusions: Proliferation index Ki67 is not a reliable prognostic factor of craniopharyngioma’s recurrence.

12 October 2020 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
ABAgnieszka Bogusz-Wójcik
Agnieszka Bogusz-Wójcik
HKHonorata Kołodziejczyk
Honorata Kołodziejczyk
MKMaja Klaudel-Dreszler
Maja Klaudel-Dreszler
GOGrzegorz Oracz
Grzegorz Oracz
JPJoanna Pawłowska
Joanna Pawłowska
MSMieczysław Szalecki
Mieczysław Szalecki
Background: Shwachman-Diamond syndrome (SDS) is a rare genetic, multi-systemic disease characterized by exocrine pancreatic insufficiency, immune deficiency, bone marrow failure and skeletal abnormalities. Most patients present with failure in somatic development and short stature, but systematic data concerning those features are limited. The aim of the study was to assess the prevalence of failure in somatic development in the children with SDS. Methods: An analysis of anthropometric measurements of 21 patients (14 girls and 7 boys),aged 2 to 17 years (mean age 6.3 years) with SDS diagnosed in The Children’s Memorial Health Institute in Warsaw, Poland was performed. The patients were measured using a Holtain Limited stadiometer, an electronic scale, a Harpenden anthropometer, a metric tape and a spreading caliper. The assessed anthropometric parameters were expressed as standard deviation scores in relation to the reference values in Poland, suitable for sex as well as calendar and growth age. Results: A total of 66 measurements was collected and analyzed with a median number of 3 observations per patient. The group of boys presented with a significantly lower height (− 3.0 SD, p < 0.0001) and BMI (− 1.4 SD, p < 0.00001), and in the relation to the growth age a lower weight (− 1.0 SD, p < 0.001) as well as a smaller chest width (− 0.9 SD, p < 0.05), hip width (− 0,5 SD, p < 0,05) and lower limb length (− 0,5 SD, p < 0,05). The group of girls also showed significantly lower height (− 2.6 SD, p < 0.00001) and BMI (− 0.8 SD, p < 0.00001), and in relation to the growth age, lower weight (− 0.5 SD, p < 0.001) as well as decreased width of the chest (− 1.7 SD, p < 0.0001) and shoulder (− 1.0 SD, p < 0.001) were observed. Boys and girls were also characterized by significantly decreased circumference and width of head, additionally, girls had also smaller head length. Conclusions: Patients with SDS have abnormal somatic development. Both boys and girls are characterized by short stature, decreased weight, BMI, leg length, chest width as well as circumference and width of head. Anthropometric measurements provide important data on the process of growth and body proportions in children with SDS.